Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review

Andrea Lombardi, Andrea Gramegna, Margherita Ori, Cecilia Azzarà, Francesco Blasi, Andrea Gori
ERJ Open Research 2022; DOI: 10.1183/23120541.00364-2022
Andrea Lombardi
1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Lombardi
Andrea Gramegna
2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
3Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margherita Ori
3Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Azzarà
1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cecilia Azzarà
Francesco Blasi
2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
3Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Gori
1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrea.lombardi@unimi.it
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/23120541.00364-2022

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received July 21, 2022
  • Accepted September 8, 2022
  • Published online November 10, 2022.

Article Versions

  • You are currently viewing a previous version of this article (November 10, 2022 - 09:01).
  • View the most recent version of this article
Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Andrea Lombardi1,2,
  2. Andrea Gramegna2,3,
  3. Margherita Ori3,
  4. Cecilia Azzarà1,
  5. Francesco Blasi2,3 and
  6. Andrea Gori1,2⇑
  1. 1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  2. 2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
  3. 3Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  1. Corresponding author: Andrea Lombardi (andrea.lombardi{at}unimi.it)
View Full Text

Funding

  • Italian Ministry of Health

    Current research IRCCS 2021

Article usage

Article usage: November 2022 to December 2022

AbstractFullPdf
Nov 20228714672
Dec 20223241122

Altmetrics

PreviousNext
Back to top
Vol 9 Issue 1 Table of Contents
ERJ Open Research: 9 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review
Andrea Lombardi, Andrea Gramegna, Margherita Ori, Cecilia Azzarà, Francesco Blasi, Andrea Gori
ERJ Open Research Jan 2022, 00364-2022; DOI: 10.1183/23120541.00364-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review
Andrea Lombardi, Andrea Gramegna, Margherita Ori, Cecilia Azzarà, Francesco Blasi, Andrea Gori
ERJ Open Research Jan 2022, 00364-2022; DOI: 10.1183/23120541.00364-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis
  • Incidence of cognitive impairment and dementia after hospitalisation for pneumonia: a UK population-based matched cohort study
  • Validation of the HULL Score clinical prediction rule (CPR) for unsuspected pulmonary embolism in ambulatory cancer patients
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society